These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 24219827)

  • 1. Mortality associated with proton pump inhibitors in cirrhotic patients with spontaneous bacterial peritonitis.
    Kwon JH; Koh SJ; Kim W; Jung YJ; Kim JW; Kim BG; Lee KL; Im JP; Kim YJ; Kim JS; Yoon JH; Lee HS; Jung HC
    J Gastroenterol Hepatol; 2014 Apr; 29(4):775-81. PubMed ID: 24219827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased rate of spontaneous bacterial peritonitis among cirrhotic patients receiving pharmacologic acid suppression.
    Goel GA; Deshpande A; Lopez R; Hall GS; van Duin D; Carey WD
    Clin Gastroenterol Hepatol; 2012 Apr; 10(4):422-7. PubMed ID: 22155557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites.
    Bajaj JS; Zadvornova Y; Heuman DM; Hafeezullah M; Hoffmann RG; Sanyal AJ; Saeian K
    Am J Gastroenterol; 2009 May; 104(5):1130-4. PubMed ID: 19337238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acid-suppressive therapy is associated with spontaneous bacterial peritonitis in cirrhotic patients: a meta-analysis.
    Deshpande A; Pasupuleti V; Thota P; Pant C; Mapara S; Hassan S; Rolston DD; Sferra TJ; Hernandez AV
    J Gastroenterol Hepatol; 2013 Feb; 28(2):235-42. PubMed ID: 23190338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of proton pump inhibitors in the occurrence and the prognosis of spontaneous bacterial peritonitis in cirrhotic patients with ascites.
    de Vos M; De Vroey B; Garcia BG; Roy C; Kidd F; Henrion J; Deltenre P
    Liver Int; 2013 Oct; 33(9):1316-23. PubMed ID: 23730823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed paracentesis is associated with increased in-hospital mortality in patients with spontaneous bacterial peritonitis.
    Kim JJ; Tsukamoto MM; Mathur AK; Ghomri YM; Hou LA; Sheibani S; Runyon BA
    Am J Gastroenterol; 2014 Sep; 109(9):1436-42. PubMed ID: 25091061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between acid suppressive therapy and spontaneous bacterial peritonitis in cirrhotic patients with ascites.
    Choi EJ; Lee HJ; Kim KO; Lee SH; Eun JR; Jang BI; Kim TN
    Scand J Gastroenterol; 2011 May; 46(5):616-20. PubMed ID: 21275825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The predictive value of end-stage liver disease model for spontaneous bacterial peritonitis in cirrhotic patients with ascites].
    Wang X; Wang BM; Jiang K; Zhang J; Fang WL; Wang T; Li XY
    Zhonghua Nei Ke Za Zhi; 2009 Aug; 48(8):629-32. PubMed ID: 19954052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton pump inhibitor use significantly increases the risk of spontaneous bacterial peritonitis in 1965 patients with cirrhosis and ascites: a propensity score matched cohort study.
    Min YW; Lim KS; Min BH; Gwak GY; Paik YH; Choi MS; Lee JH; Kim JJ; Koh KC; Paik SW; Yoo BC; Rhee PL
    Aliment Pharmacol Ther; 2014 Sep; 40(6):695-704. PubMed ID: 25078671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between model for end-stage liver disease and spontaneous bacterial peritonitis.
    Obstein KL; Campbell MS; Reddy KR; Yang YX
    Am J Gastroenterol; 2007 Dec; 102(12):2732-6. PubMed ID: 17714556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton pump inhibitor intake neither predisposes to spontaneous bacterial peritonitis or other infections nor increases mortality in patients with cirrhosis and ascites.
    Mandorfer M; Bota S; Schwabl P; Bucsics T; Pfisterer N; Summereder C; Hagmann M; Blacky A; Ferlitsch A; Sieghart W; Trauner M; Peck-Radosavljevic M; Reiberger T
    PLoS One; 2014; 9(11):e110503. PubMed ID: 25369194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 22/11 risk prediction model: a validated model for predicting 30-day mortality in patients with cirrhosis and spontaneous bacterial peritonitis.
    Tandon P; Kumar D; Seo YS; Chang HJ; Chaulk J; Carbonneau M; Qamar H; Keough A; Mansoor N; Ma M
    Am J Gastroenterol; 2013 Sep; 108(9):1473-9. PubMed ID: 23877350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton pump inhibitor therapy does not increase the incidence of spontaneous bacterial peritonitis in cirrhosis: a multicenter prospective study.
    Terg R; Casciato P; Garbe C; Cartier M; Stieben T; Mendizabal M; Niveyro C; Benavides J; Marino M; Colombato L; Berbara D; Silva M; Salgado P; Barreyro F; Fassio E; Gadano A;
    J Hepatol; 2015 May; 62(5):1056-60. PubMed ID: 25481567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton pump inhibitor use is associated with spontaneous bacterial peritonitis in patients with liver cirrhosis.
    Miura K; Tanaka A; Yamamoto T; Adachi M; Takikawa H
    Intern Med; 2014; 53(10):1037-42. PubMed ID: 24827481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors Affecting Mortality and Morbidity of Patients With Cirrhosis Hospitalized for Spontaneous Bacterial Peritonitis.
    Ensaroğlu F; Korkmaz M; Geçkil AÜ; Öcal S; Koç B; Yıldız Ö; Atalay FB; Taş EG; Haberal M
    Exp Clin Transplant; 2015 Nov; 13 Suppl 3():131-6. PubMed ID: 26640933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton pump inhibitors do not increase the risk for recurrent spontaneous bacterial peritonitis in patients with cirrhosis.
    Kim JH; Lim KS; Min YW; Lee H; Min BH; Rhee PL; Kim JJ; Koh KC; Paik SW
    J Gastroenterol Hepatol; 2017 May; 32(5):1064-1070. PubMed ID: 28449345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacteremia is a prognostic factor for poor outcome in spontaneous bacterial peritonitis.
    Cho JH; Park KH; Kim SH; Bang JH; Park WB; Kim HB; Kim NJ; Oh MD; Lee HS; Choe KW
    Scand J Infect Dis; 2007; 39(8):697-702. PubMed ID: 17654346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton pump inhibitors as a risk factor for hepatic encephalopathy and spontaneous bacterial peritonitis in patients with cirrhosis with ascites.
    Dam G; Vilstrup H; Watson H; Jepsen P
    Hepatology; 2016 Oct; 64(4):1265-72. PubMed ID: 27474889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton pump inhibitor therapy and its association with spontaneous bacterial peritonitis incidence and mortality: A meta-analysis.
    Yu T; Tang Y; Jiang L; Zheng Y; Xiong W; Lin L
    Dig Liver Dis; 2016 Apr; 48(4):353-9. PubMed ID: 26795544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between proton pump inhibitor use and spontaneous bacterial peritonitis in cirrhotic patients with ascites.
    Ratelle M; Perreault S; Villeneuve JP; Tremblay L
    Can J Gastroenterol Hepatol; 2014 Jun; 28(6):330-4. PubMed ID: 24945188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.